These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. How commercialization puts a blight on research. Laver G; Müllbacher A; Waring P Nature; 2001 Aug; 412(6849):765. PubMed ID: 11518937 [No Abstract] [Full Text] [Related]
24. The economics of pharmaceutical price regulation and importation: refocusing the debate. Vernon JA; Golec JH; Hughen WK Am J Law Med; 2006; 32(2-3):175-92. PubMed ID: 16927609 [No Abstract] [Full Text] [Related]
25. 2 billion euro IMI launched with European pharma. Hodgson J Nat Biotechnol; 2008 Jul; 26(7):717-8. PubMed ID: 18612274 [No Abstract] [Full Text] [Related]
26. Payers growing influence on R&D decision making. Hughes B Nat Rev Drug Discov; 2008 Nov; 7(11):876-8. PubMed ID: 18974741 [No Abstract] [Full Text] [Related]
27. When there's no room to grow. Ledford H Nature; 2008 Jul; 454(7201):144-5. PubMed ID: 18615042 [No Abstract] [Full Text] [Related]
28. [Center for Human Growth and Development. University of Michigan, Ann Arbor]. Duterloo HS Ned Tijdschr Tandheelkd; 1969 Feb; 76(2):146-8. PubMed ID: 5250320 [No Abstract] [Full Text] [Related]
30. [Drug industry in India is threatened by free trade agreement]. Jeppsson A Lakartidningen; 2009 Oct 7-13; 106(41):2589. PubMed ID: 19927922 [No Abstract] [Full Text] [Related]
31. Swiss company takes a 60 per cent stake in Genentech. Gershon D Nature; 1990 Feb; 343(6258):495. PubMed ID: 2300193 [No Abstract] [Full Text] [Related]
32. Where does novel antibiotics R&D stand among other pharmaceutical products: an industrial perspective? Tillotson GS Expert Rev Anti Infect Ther; 2008 Oct; 6(5):551-2. PubMed ID: 18847393 [No Abstract] [Full Text] [Related]
33. Deals landscape: notable deals in the pharmaceutical industry in the third quarter of 2008. Glah D; Tear S IDrugs; 2008 Nov; 11(11):841-5. PubMed ID: 19024888 [No Abstract] [Full Text] [Related]
34. Mixed scores for European research. Chipman A Nature; 2007 Nov; 450(7166):16-7. PubMed ID: 17972849 [No Abstract] [Full Text] [Related]
37. Overcoming further challenges in the pharma/biotech industry: 2007 update. Graul AI; Cruces E; Revel L; Serradell N; Rosa E Drug News Perspect; 2008; 21(1):44-58. PubMed ID: 18301809 [TBL] [Abstract][Full Text] [Related]
38. Pharmaceutical industry financial performance. Goodman M Nat Rev Drug Discov; 2009 Dec; 8(12):927-8. PubMed ID: 19949398 [No Abstract] [Full Text] [Related]
39. January 2009, Taliban and the end of trick or treating. Thomasson J Mo Med; 2009; 106(2):112-3. PubMed ID: 19397107 [No Abstract] [Full Text] [Related]
40. MEDICAL-PERSONAL relations in industry; discussional; University of Michigan School of Public Health, Ann Arbor, Michigan, May 17, 18, 19, 1951. Ind Med Surg; 1952 Jan; 21(1):28-34. PubMed ID: 14907132 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]